The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Jan. 14, 2013
Applicant:

Santen Pharmaceutical Co., Ltd., Osaka, JP;

Inventors:

Sreenivasu Mudumba, Union City, CA (US);

Philippe J M Dor, Kirkland, WA (US);

Thierry Nivaggioli, Atherton, CA (US);

David A. Weber, Danville, CA (US);

Sidiq Farooq, Newark, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/13 (2006.01); A61K 31/436 (2006.01); A61K 31/045 (2006.01); A61K 47/10 (2006.01); A61K 9/00 (2006.01); A61K 47/44 (2006.01); A61K 31/44 (2006.01); A61K 31/4745 (2006.01); A61K 47/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 31/436 (2013.01); A61K 31/045 (2013.01); A61K 47/10 (2013.01); A61K 9/0019 (2013.01); A61K 47/44 (2013.01); A61K 31/44 (2013.01); A61K 31/4745 (2013.01); A61K 47/12 (2013.01);
Abstract

Described herein are liquid formulations which deliver a variety of therapeutic agents, including but not limited to rapamycin, to a subject for an extended period of time; liquid formulations which form a non-dispersed mass when placed in an aqueous medium of a subject; liquid formulations, comprising a therapeutic agent and a plurality of polymers; and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations. The liquid formulation may be placed in an aqueous medium of a subject, including but not limited to via intraocular or periocular administration. A method may be used to administer rapamycin to treat or prevent angiogenesis, choroidal neovascularization, or age-related macular degeneration in a subject.


Find Patent Forward Citations

Loading…